propafenone / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
propafenone / Generic mfg.
NCT01709682: A Comparison of the Drug Therapy Versus Re-Ablation

Completed
2
154
RoW
Anti-Arrhythmia Agents (propafenone, flecainide, and/or sotalol, or amiodarone), re-ablation procedure, ILR implantation
Meshalkin Research Institute of Pathology of Circulation
Paroxysmal Atrial Fibrillation, Failed First Radiofrequency Ablation Procedure
01/12
08/12
NCT02710669: New Formulations of Propafenone to Treat Atrial Fibrillation

Terminated
1/2
193
US
(R)-propafenone, (S)-Propafenone, Placebo
Vanderbilt University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
03/20
04/20

Download Options